Page last updated: 2024-08-22

angiotensin ii and Hyperglycemia

angiotensin ii has been researched along with Hyperglycemia in 94 studies

Research

Studies (94)

TimeframeStudies, this research(%)All Research%
pre-19908 (8.51)18.7374
1990's15 (15.96)18.2507
2000's37 (39.36)29.6817
2010's32 (34.04)24.3611
2020's2 (2.13)2.80

Authors

AuthorsStudies
Bai, HY; Gu, HB; Li, H; Shan, BS; Zhou, X1
Capozzi, ME; Padovani-Claudio, DA; Penn, JS; Ramos, CJ1
Advani, A; Cherney, DZI; Fong, D; Har, R; Lai, V; Locke, A; Lytvyn, Y; Perkins, BA1
de Queiroz, DB; Duarte, GP; Ramos-Alves, FE; Santos-Rocha, J; Xavier, FE1
Fang, WJ; Shyu, KG; Wang, BW1
Abu Hamad, R; Berman, S; Efrati, S1
Chhabra, KH; Lazartigues, E; Pedersen, KB; Speth, RC; Xia, H1
Liu, ML; Qiu, Q; Wang, L; Wu, XL; Xu, YZ; Zhang, F; Zhang, GR; Zhang, X1
Auger, C; Kang, M; Kim, KR; Lee, JO; Oak, MH; Park, DH; Schini-Kerth, VB1
Abdul, A; Deb, DK; Heilig, CW; James, LR; Nahman, NS; Riaz, H; Salameh, J1
Cherney, DZ; Maahs, DM; Perkins, BA; Yang, GK1
Bigagli, E; Lodovici, M; Manni, ME; Musilli, C; Raimondi, L; Zazzeri, M1
Cai, L; Fang, Q; Huang, Y; Liang, G; Miao, L; Pan, Y; Peng, K; Sun, Y; Tong, C; Wang, Y; Wang, Z; Zhao, Y1
Kotov, AV; Pevtsova, EI; Shoibonov, BB; Tolpygo, SM1
De Mello, WC1
Bagal, S; Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A1
Harris, NR; Lee, S1
Kawasaki, H; Kitamura, Y; Mio, M; Miyashita, S; Takatori, S; Yamawaki, K; Zamami, Y1
Averbukh, Z; Berman, S; Efrati, S; Tov, YS; Weissgarten, J1
Fukumoto, M; Hayashi, T; Ikeda, T; Jin, D; Kitaura, Y; Miyazaki, M; Oku, H; Sugiyama, T; Takai, S1
Aoyama, I; Bomsztyk, K; Komers, R; Koopmeiners, JS; Naito, M; Schnaper, HW; Shenoy, A1
De Geest, B; Egorova, M; Jacobs, F; Lorenz, M; Meloni, M; Schultheiss, HP; Spillmann, F; Stangl, V; Tschöpe, C; Van Linthout, S1
Hua, P; Jaimes, EA; Raij, L; Tian, RX1
Han, HJ; Kim, YH; Lee, YJ; Ryu, JM1
Bradley, TJ; Cherney, DZ; Dekker, MG; Lai, V; Miller, JA; Reich, HN; Scholey, JW; Sochett, EB; Zinman, B1
Huang, Y; Lu, LM; Ni, J; Xue, H; Yu, C; Yuan, P; Zhou, L1
Barnes, JL; Cavaglieri, Rde C; Day, RT; Feliers, D; Kasinath, BS; Lee, MJ; Mantravadi, V; Tabatabaimir, H1
Abdulla, MH; Abdullah, NA; Anand Swarup, KR; Hye Khan, MA; Johns, EJ; Sattar, MA1
Baker, KM; Choudhary, R; Guleria, RS; Pan, J; Tanaka, T1
Abdulla, MH; Abdullah, NA; Hye Khan, MA; Johns, EJ; Rathore, HA; Sattar, MA1
Lee, KO; Sim, MK; Wong, YC1
Akhtar, S; Al-Farsi, O; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH1
Berman, S; Chanimov, M; Efrati, S; Hamad, RA; Siman-Tov, Y; Weissgarten, J1
Leung, KK; Leung, PS; Liang, J; Ma, MT1
Baker, KM; Kumar, R; Thomas, CM; Yong, QC1
Bradley, TJ; Cherney, DZ; Lai, V; Reich, HN; Scholey, JW; Slorach, C; Zinman, B1
Chihara, Y; Denda, A; Fujii, K; Kuniyasu, H; Luo, Y; Ohmori, H; Sasahira, T; Shimomoto, T; Tatsumoto, N1
Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH1
Müller-Fielitz, H; Raasch, W1
Kotov, AV; Loseva, TN; Pevtsova, EI; Tolpygo, SM1
Kanwar, YS; Sahai, A; Sodhi, CP1
Mohanram, A; Toto, RD1
Bolick, DT; Hatley, ME; Hedrick, CC; Nadler, JL; Srinivasan, S1
Funatsu, H; Yamashita, H1
Amiri, F; Banes, AK; Jenkins, J; Marrero, MB; Pollock, DM; Redd, H; Shaw, S1
Arun, KH; Kaul, CL; Poduri, R1
De Vriese, AS; Flyvbjerg, A; Schrijvers, BF1
Mozaffari, M; Pastukh, V; Ricci, C; Schaffer, S; Wu, S1
Wang, YX1
Chen, KY; Chuang, M; Hunt, D; Kargacin, G; Severson, DL; Shimoni, Y1
Kadowaki, T; Yamamoto-Honda, R1
Nagaria, AM; Reddy, S; Savin, VJ; Sharma, M; Sharma, R; Wiegmann, TB1
Cooper, ME; Thomas, MC; Tikellis, C1
Cai, H; Oak, JH1
Arafat, HA; Chipitsyna, G; Gong, Q; Gray, CF; Haroon, Y; Kamer, E1
Gaikwad, AB; Ramarao, P; Viswanad, B1
Han, HJ; Lee, YJ1
Casarini, DE; Fiorino, P; Irigoyen, MC; Lagranha, CJ; Schaan, BD1
Gao, L; Kern, TS; Xi, X; Zhang, JZ1
Camussi, G; Gruden, G; Perin, PC1
Fulton, D; Marrero, MB; Stepp, D; Stern, DM1
Jong, CJ; Ricci, C; Schaffer, SW1
Leung, KK; Leung, PS1
Blantz, RC; Pelayo, JC1
Coimbra, CC; Machado, LJ; Marubayashi, U; Mihessen-Neto, I; Reis, AM1
Griffin, CA; Schambelan, M; Sechi, LA1
Elton, TS; Guest, LL; Marchase, RB; Rivera, AA; White, CR1
Coimbra, CC; Machado, LJ; Marubayashi, U; Reis, AM2
Bai, W; Gonzales, N; Lanting, L; Nadler, J; Natarajan, R1
Faraday, N; Nguyen, ND; Rosenfeld, BA; Sung, I1
McCarty, MF1
Grupp, LA; Harding, S; Lau, V1
Dusting, GJ; Ritchie, RH; Rosenkranz, AC1
Miller, JA1
Coimbra, CC; Foscolo, DR; Garofalo, MA; Migliorini, RH; Xavier, AR1
Amiri, F; Ju, H; Marrero, MB; Venema, RC; Venema, VJ; Wang, X1
Hollenberg, NK; Laffel, LM; Lansang, MC; Osei, SY; Price, DA1
Andersson, A; Carlsson, PO; Jansson, L; Olsson, R1
Broadbent, DM1
Brownlee, M; Draznin, B; Goalstone, ML; Golovchenko, I; Watson, P1
Anversa, P; Cesselli, D; Fiordaliso, F; Kajstura, J; Leri, A; Limana, F; Nadal-Ginard, B; Safai, B1
Srivastava, AK1
Du, J; Fujisawa, G; Fujita, N; Furukawa, Y; Ishibashi, S; Itabashi, N; Okada, K; Saito, T1
Brodbeck, K; Häring, HU; Klopfer, K; Schleicher, ED; Weigert, C1
Assal, JP; Christlieb, AR; Katsilambros, N; Kozak, GP; Suzuki, T; Williams, GH1
Hetey, L; Konitzer, K; Voigt, S1
Simmons, DA; Winegrad, AI1
Andreis, PG; Cavallini, L; Mazzocchi, G; Nussdorfer, GG; Rebuffat, P1
Brown, MR; Fisher, LA1
Clements, RS; Morrison, AD; Winegrad, AI1
Masumura, S; Ono, K1
Hori, S; Masumura, S; Ono, K1
Hori, S; Masumura, S; Ono, K; Sato, Y1

Reviews

18 review(s) available for angiotensin ii and Hyperglycemia

ArticleYear
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.
    Progress in retinal and eye research, 2023, Volume: 94

    Topics: Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans; Hyperglycemia; Hypertension; Neuroglia; Palmitic Acid

2023
GLUT1 regulation of the pro-sclerotic mediators of diabetic nephropathy.
    American journal of nephrology, 2013, Volume: 38, Issue:1

    Topics: Angiotensin II; Animals; Connective Tissue Growth Factor; Diabetic Nephropathies; Glucose; Glucose Transporter Type 1; Humans; Hyperglycemia; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A

2013
Intracellular angiotensin II disrupts chemical communication and impairs metabolic cooperation between cardiac myocytes.
    Peptides, 2015, Volume: 72

    Topics: Angiotensin II; Animals; Cell Communication; Heart Failure; Humans; Hyperglycemia; Myocardial Ischemia; Myocytes, Cardiac; Renin-Angiotensin System

2015
Intracardiac intracellular angiotensin system in diabetes.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Mar-01, Volume: 302, Issue:5

    Topics: Angiotensin II; Animals; Cricetinae; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Heart; Hyperglycemia; Mice; Myocardium; Rats; Renin-Angiotensin System

2012
Outcome studies in diabetic nephropathy.
    Seminars in nephrology, 2003, Volume: 23, Issue:3

    Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension, Renal; Irbesartan; Kidney Failure, Chronic; Male; Outcome Assessment, Health Care; Proteinuria; Renin-Angiotensin System; Risk Factors; Smoking; Tetrazoles

2003
Pathogenesis of diabetic retinopathy and the renin-angiotensin system.
    Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2003, Volume: 23, Issue:6

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetic Retinopathy; Disease Progression; Humans; Hyperglycemia; Hypertension; Macular Degeneration; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Vascular Endothelial Growth Factors

2003
From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.
    Endocrine reviews, 2004, Volume: 25, Issue:6

    Topics: Aldehyde Reductase; Angiotensin II; Animals; Cytokines; Diabetic Nephropathies; Diglycerides; Endothelins; Glycation End Products, Advanced; Growth Substances; Hemodynamics; Humans; Hyperglycemia; Nitric Oxide; Protein Kinases

2004
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
    Neurobiology of aging, 2005, Volume: 26, Issue:3

    Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin

2005
[Protein kinase C activation and diabetic complications].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6

    Topics: Angiotensin II; Animals; Diabetes Complications; Diglycerides; Enzyme Activation; Glycation End Products, Advanced; Humans; Hyperglycemia; Isoenzymes; Polymers; Protein Kinase C; Reactive Oxygen Species

2005
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
    Frontiers in bioscience : a journal and virtual library, 2006, Jan-01, Volume: 11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glucose; Hyperglycemia; Immunoblotting; Insulin; Insulin Resistance; Kidney; Male; Models, Statistical; Obesity; Proteinuria; Radioimmunoassay; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation

2006
Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
    The international journal of biochemistry & cell biology, 2006, Volume: 38, Issue:5-6

    Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrosis; Humans; Hyperglycemia; Hypoglycemia; Islets of Langerhans; Pancreas; Peptidyl-Dipeptidase A; PPAR gamma; Receptors, Angiotensin; Renin; Renin-Angiotensin System

2006
Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.
    Kidney international. Supplement, 2007, Issue:106

    Topics: Angiotensin II; Animals; Diabetic Nephropathies; Dogs; Epidermal Growth Factor; ErbB Receptors; Glucose; Humans; Hyperglycemia; Kidney Tubules, Proximal; Mice; Rabbits; Rats; Sodium-Glucose Transport Proteins

2007
[Molecular bases of diabetic nephropathy].
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:6

    Topics: Angiotensin II; Cell Proliferation; Diabetic Nephropathies; Endothelium-Dependent Relaxing Factors; Extracellular Matrix; Glomerular Mesangium; Glucose Transporter Type 1; Glycation End Products, Advanced; Humans; Hyperglycemia; Nitric Oxide; Oxidative Stress; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta1; Vasoconstrictor Agents

2007
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.
    Current diabetes reviews, 2005, Volume: 1, Issue:1

    Topics: Angiotensin II; Connective Tissue Growth Factor; Diabetic Nephropathies; Extracellular Matrix; Glomerular Mesangium; Glucose Transporter Type 1; Glycosylation; Hexosamines; Humans; Hyperglycemia; Immediate-Early Proteins; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; Nitric Oxide; Podocytes; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A

2005
Angiotensin II-induced signaling pathways in diabetes.
    Current diabetes reviews, 2005, Volume: 1, Issue:2

    Topics: Angiotensin II; Cell Division; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Glomerular Mesangium; Glycation End Products, Advanced; Humans; Hyperglycemia; Muscle, Smooth, Vascular; Reactive Oxygen Species; Signal Transduction

2005
A functional role for the tubuloglomerular feedback mechanism.
    Kidney international, 1984, Volume: 25, Issue:5

    Topics: Acute Kidney Injury; Angiotensin II; Animals; Benzolamide; Diuretics; Feedback; Glomerular Filtration Rate; Homeostasis; Humans; Hydrostatic Pressure; Hyperglycemia; Kidney Glomerulus; Kidney Tubules; Nephrons; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Ultrafiltration

1984
Diabetic eye disease: how can it be prevented?
    The Practitioner, 2000, Volume: 244, Issue:1613

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Retinopathy; Humans; Hyperglycemia; Laser Therapy; Risk Factors

2000
High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
    International journal of molecular medicine, 2002, Volume: 9, Issue:1

    Topics: Angiotensin II; Animals; Diabetes Mellitus; Diabetic Angiopathies; Enzyme Activation; Hyperglycemia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NF-kappa B; Protein Kinase C

2002

Trials

3 trial(s) available for angiotensin ii and Hyperglycemia

ArticleYear
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:1

    Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Female; Glucose Clamp Technique; Hemodynamics; Humans; Hyperglycemia; Indoles; Infusions, Intravenous; Male; Maleimides; Pilot Projects; Protein Kinase C; Protein Kinase C beta; Renin-Angiotensin System

2012
Neuroendocrine stress hormones do not recreate the postoperative hypercoagulable state.
    Anesthesia and analgesia, 1998, Volume: 86, Issue:3

    Topics: Adult; Angiotensin II; Blood Coagulation; Epinephrine; Female; Glucagon; Hemodynamics; Humans; Hydrocortisone; Hyperglycemia; Leukocyte Count; Male; Norepinephrine; Plasminogen Activator Inhibitor 1; Platelet Count; Postoperative Period; Protein C; Stress, Physiological; Time Factors; Tissue Plasminogen Activator; Vasopressins

1998
Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.
    Journal of the American Society of Nephrology : JASN, 1999, Volume: 10, Issue:8

    Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Humans; Hyperglycemia; Kidney; Losartan; Male; Natriuresis; Renal Circulation; Renin-Angiotensin System; Vascular Resistance

1999

Other Studies

73 other study(ies) available for angiotensin ii and Hyperglycemia

ArticleYear
AT2 Receptor Stimulation Inhibits Vascular Smooth Muscle Cell Senescence Induced by Angiotensin II and Hyperglycemia.
    American journal of hypertension, 2022, 10-03, Volume: 35, Issue:10

    Topics: Angiotensin II; Animals; Carrier Proteins; Cells, Cultured; Cellular Senescence; Glucose; Hyperglycemia; Imidazoles; Male; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptor, Angiotensin, Type 2; Sirolimus; Sulfonamides; Superoxides; Thiophenes

2022
Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.
    Diabetes, 2017, Volume: 66, Issue:7

    Topics: Adult; Angiotensin II; Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 1; Febuxostat; Female; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperglycemia; Interleukin-18; Linear Models; Male; Nitric Oxide; Nitroglycerin; Renal Plasma Flow, Effective; Renin-Angiotensin System; Uric Acid; Vascular Stiffness; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Young Adult

2017
Losartan reverses COX-2-dependent vascular dysfunction in offspring of hyperglycaemic rats.
    Life sciences, 2017, Sep-01, Volume: 184

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 2; Endothelium, Vascular; Female; Hyperglycemia; Losartan; Male; Mesenteric Arteries; Pregnancy; Rats; Rats, Wistar; Vasoconstriction; Vasodilation

2017
MicroRNA-145 regulates disabled-2 and Wnt3a expression in cardiomyocytes under hyperglycaemia.
    European journal of clinical investigation, 2018, Volume: 48, Issue:1

    Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Apoptosis; beta Catenin; Blood Glucose; Diabetes Mellitus, Experimental; Heart Ventricles; Hyperglycemia; Male; MicroRNAs; Myocardium; Myocytes, Cardiac; Rats, Wistar; Wnt3 Protein

2018
Mesangial cells are responsible for orchestrating the renal podocytes injury in the context of malignant hypertension.
    Nephrology (Carlton, Vic.), 2013, Volume: 18, Issue:4

    Topics: Angiotensin II; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Glucose; Hydrostatic Pressure; Hyperglycemia; Hypertension, Malignant; Mesangial Cells; Paracrine Communication; Podocytes; Rats

2013
Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
    American journal of physiology. Endocrinology and metabolism, 2013, Apr-15, Volume: 304, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Adenoviridae; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Genetic Therapy; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Vasoconstrictor Agents

2013
An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:8

    Topics: Adiponectin; Adult; Angiotensin II; Biomarkers; Blood Circulation; Fatty Liver; Humans; Hyperglycemia; Male; Metabolism, Inborn Errors; Middle Aged; Non-alcoholic Fatty Liver Disease

2013
An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Albuminuria; Angiotensin II; Animals; Aorta; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelium, Vascular; Ethanol; Exercise Tolerance; Gene Expression; Humans; Hyperglycemia; Hypoglycemic Agents; Lindera; Male; Mice; Mice, Transgenic; NADPH Oxidases; Nitric Oxide Synthase Type III; Pioglitazone; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Receptor, Angiotensin, Type 1; Thiazolidinediones

2013
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glucose Clamp Technique; Heart Rate; Humans; Hyperglycemia; Kidney; Male; Renin

2013
Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: implications in heart failure.
    European journal of pharmacology, 2013, Oct-15, Volume: 718, Issue:1-3

    Topics: Aldehyde Dehydrogenase; Angiotensin II; Animals; Biphenyl Compounds; Catalase; Enzyme Activation; Heart Failure; Hyperglycemia; Irbesartan; Losartan; Monoamine Oxidase; Myocytes, Cardiac; Rats; Tetrazoles

2013
Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:2

    Topics: Angiotensin II; Animals; Benzylidene Compounds; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Streptozocin

2014
Comparative study of the effects of free bound and carrier protein angiotensin II in experimental hypoglycemia and hyperglycemia.
    Bulletin of experimental biology and medicine, 2014, Volume: 156, Issue:4

    Topics: Angiotensin II; Animals; Blood Pressure; Drinking Behavior; Heart Rate; Hyperglycemia; Hypoglycemia; Male; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; Serum Albumin, Bovine; Thirst

2014
Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia.
    Biochemical and biophysical research communications, 2015, May-29, Volume: 461, Issue:2

    Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Aorta; Blood Pressure; Diabetes Mellitus, Experimental; Hyperglycemia; Hyperinsulinism; Hypertension; Male; Peptidyl-Dipeptidase A; Rats, Wistar; Transforming Growth Factor beta; Umbelliferones

2015
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.
    Microcirculation (New York, N.Y. : 1994), 2008, Volume: 15, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Blood Flow Velocity; Constriction, Pathologic; Female; Fibrinolytic Agents; Hyperglycemia; Losartan; Methacrylates; Mice; Mice, Inbred NOD; Retinal Vessels; Thromboxanes; Venules

2008
Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:5

    Topics: Acetylcholine; Acute Disease; Adrenergic Fibers; Angiotensin II; Animals; Calcitonin Gene-Related Peptide; Glucose; Hyperglycemia; Hyperinsulinism; Male; Nitroprusside; Norepinephrine; Octreotide; Rats; Rats, Wistar; Spinal Cord Injuries; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2008
Hyperglycemia alters renal cell responsiveness to pressure in a model of malignant hypertension.
    Journal of hypertension, 2009, Volume: 27, Issue:2

    Topics: Angiotensin II; Animals; Apoptosis; Cell Line; Cell Proliferation; Endothelial Cells; Epithelial Cells; Hydrogen Peroxide; Hydrostatic Pressure; Hyperglycemia; Hypertension, Malignant; Kidney; Mesangial Cells; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53

2009
Long-term angiotensin II blockade may improve not only hyperglycemia but also age-associated cardiac fibrosis.
    Journal of pharmacological sciences, 2009, Volume: 109, Issue:2

    Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fibrosis; Heart Failure; Hyperglycemia; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Tetrazoles

2009
High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.
    American journal of nephrology, 2009, Volume: 30, Issue:2

    Topics: Angiotensin II; Gene Expression Regulation; Glucose; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Inflammation; Kidney; Mesangial Cells; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Tetrazoles; Valine; Valsartan

2009
Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:4

    Topics: Angiotensin II; Animals; Aorta; Apolipoprotein A-I; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dimerization; Down-Regulation; Endothelium, Vascular; Gene Transfer Techniques; Humans; Hyperglycemia; Lipoproteins, HDL; Male; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction

2009
Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress.
    American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:1

    Topics: Angiotensin II; Cells, Cultured; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelium; Epoprostenol; Fatty Acids, Nonesterified; Glucose; Humans; Hyperglycemia; Kidney Glomerulus; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Oxygen; Reactive Oxygen Species; Superoxides

2010
Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1.
    Journal of cellular physiology, 2010, Volume: 223, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Calcium Signaling; Cell Count; Cell Proliferation; DNA Replication; Embryonic Stem Cells; Fibronectins; Glucose; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Losartan; Mice; Phosphorylation; Protein Kinase C; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta1

2010
Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2010, Volume: 299, Issue:1

    Topics: Adolescent; Adult; Aging; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glucose Clamp Technique; Hemodynamics; Humans; Hyperglycemia; Kidney; Male; Polyuria; Renal Plasma Flow, Effective; Renin-Angiotensin System; Thirst; Vascular Resistance

2010
Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:9

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Cadherins; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Extracellular Matrix; Fibronectins; Glucose; Hyperglycemia; Kidney; Kidney Tubules, Proximal; Losartan; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta1

2010
Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2).
    Cellular signalling, 2010, Volume: 22, Issue:12

    Topics: Angiotensin II; Animals; Female; Gene Expression Regulation; Heterogeneous-Nuclear Ribonucleoprotein K; Hyperglycemia; Imidazoles; Kidney; Kidney Cortex; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Receptor, Angiotensin, Type 2; RNA, Messenger; Signal Transduction; Time Factors; Vascular Endothelial Growth Factor A

2010
The contribution of α1B-adrenoceptor subtype in the renal vasculature of fructose-fed Sprague-Dawley rats.
    European journal of nutrition, 2011, Volume: 50, Issue:4

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Animals; Dietary Carbohydrates; Dose-Response Relationship, Drug; Fructose; Hemodynamics; Hyperglycemia; Hyperinsulinism; Hypertension; Kidney; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents

2011
Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system.
    Journal of cellular physiology, 2011, Volume: 226, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Apoptosis; Blood Glucose; Cells, Cultured; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Zucker; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Retinoic Acid; Renin-Angiotensin System; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; RNA Interference; RNA, Messenger; Signal Transduction; Time Factors; Tretinoin

2011
High-fructose feeding impacts on the adrenergic control of renal haemodynamics in the rat.
    The British journal of nutrition, 2012, Volume: 107, Issue:2

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Dietary Carbohydrates; Fructose; Hemodynamics; Hyperglycemia; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Kidney; Male; Norepinephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Angiotensin; Renal Circulation; Vasoconstrictor Agents

2012
Des-aspartate-angiotensin-I and angiotensin IV improve glucose tolerance and insulin signalling in diet-induced hyperglycaemic mice.
    Biochemical pharmacology, 2011, Nov-01, Volume: 82, Issue:9

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Cystinyl Aminopeptidase; Dietary Fats; Dietary Sucrose; Drug Administration Schedule; Glucose Intolerance; Hyperglycemia; Indomethacin; Insulin; Insulin Receptor Substrate Proteins; Janus Kinase 2; Losartan; Male; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Receptor, Angiotensin, Type 1; Signal Transduction

2011
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
    British journal of pharmacology, 2012, Volume: 165, Issue:5

    Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Diabetes Mellitus; ErbB Receptors; Glucose; Hyperglycemia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Quinazolines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Transcriptional Activation; Tyrphostins

2012
Hyperglycaemia emerging during general anaesthesia induces rat acute kidney injury via impaired microcirculation, augmented apoptosis and inhibited cell proliferation.
    Nephrology (Carlton, Vic.), 2012, Volume: 17, Issue:2

    Topics: Acute Kidney Injury; Anesthesia, General; Angiotensin II; Animals; Apoptosis; Biomarkers; Blood Glucose; Blood Pressure; Cell Proliferation; Cystatin C; Disease Models, Animal; Glucose; Hyperglycemia; Insulin; Kidney; Microcirculation; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors; Urea

2012
Angiotensin II type 2 receptor is critical for the development of human fetal pancreatic progenitor cells into islet-like cell clusters and their potential for transplantation.
    Stem cells (Dayton, Ohio), 2012, Volume: 30, Issue:3

    Topics: Angiotensin II; Animals; Cell Differentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Fetus; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Developmental; Gene Knockdown Techniques; Humans; Hyperglycemia; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Nude; Mitosis; ras Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stem Cells

2012
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer.
    Clinical & experimental metastasis, 2012, Volume: 29, Issue:8

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chymases; Colonic Neoplasms; Diabetes Complications; Diabetes Mellitus; Glucose; Glycated Hemoglobin; HT29 Cells; Humans; Hyperglycemia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Oligoribonucleotides, Antisense; Receptor, Angiotensin, Type 1; Renin; RNA Interference; RNA, Small Interfering

2012
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
    Pharmacological research, 2012, Volume: 66, Issue:3

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury

2012
Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2013, Volume: 45, Issue:2

    Topics: Adrenalectomy; Adrenocorticotropic Hormone; Angiotensin II; Animals; Blood Glucose; Corticosterone; Disease Models, Animal; Glucose Intolerance; Glucose Tolerance Test; Hyperglycemia; Hypothalamo-Hypophyseal System; Insulin; Insulin Secretion; Male; Metabolic Syndrome; Obesity; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Zucker; Up-Regulation

2013
Modification of normal activities of angiotensin II and angiotensin IV in rats with experimental hypo- and hyperglycemia.
    Bulletin of experimental biology and medicine, 2012, Volume: 153, Issue:5

    Topics: Angiotensin II; Animals; Blood Glucose; Carbohydrate Metabolism; Hemodynamics; Homeostasis; Hyperglycemia; Hypoglycemia; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Renin-Angiotensin System

2012
Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:3

    Topics: Angiotensin II; Animals; Blotting, Northern; Cell Division; Cell Hypoxia; Cells, Cultured; Glucose; Hyperglycemia; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Up-Regulation

2003
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition.
    Endocrinology, 2003, Volume: 144, Issue:12

    Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Connective Tissue Growth Factor; Cyclic AMP Response Element-Binding Protein; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pentoxifylline; Phosphorylation; Transforming Growth Factor beta; Vasoconstrictor Agents

2003
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    American journal of physiology. Renal physiology, 2004, Volume: 286, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; DNA-Binding Proteins; Enzyme Inhibitors; Hyperglycemia; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Kidney Glomerulus; Male; Milk Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrphostins

2004
Tempol augments angiotensin II-induced AT2 receptor-mediated relaxation in diabetic rat thoracic aorta.
    Journal of hypertension, 2004, Volume: 22, Issue:11

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Drug Synergism; Enzyme Inhibitors; Hyperglycemia; Male; NG-Nitroarginine Methyl Ester; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Spin Labels; Superoxide Dismutase; Tritium; Vasoconstrictor Agents; Vasodilation

2004
Reversal of hyperglycemic preconditioning by angiotensin II: role of calcium transport.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:4

    Topics: Angiotensin II; Animals; Apoptosis; Calcium; Calcium Channels, T-Type; Cardiotonic Agents; Cells, Cultured; Glucose; Hyperglycemia; Myocytes, Cardiac; Rats; Signal Transduction; Vasoconstrictor Agents

2005
Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat.
    The Journal of physiology, 2005, Aug-15, Volume: 567, Issue:Pt 1

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cells, Cultured; Diabetes Mellitus, Experimental; Female; Heart Ventricles; Hyperglycemia; Male; Membrane Potentials; Myocytes, Cardiac; Oxidative Stress; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Sex Characteristics; Superoxides

2005
Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.
    Diabetes, 2007, Volume: 56, Issue:1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Diabetes Mellitus, Experimental; Hydrogen Peroxide; Hyperglycemia; Mice; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Superoxides; Tetrazoles; Vasodilation

2007
Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
    Endocrinology, 2007, Volume: 148, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Chemokine CCL2; Diabetes Mellitus, Type 1; Gene Expression; Hyperglycemia; Imidazoles; Insulin-Secreting Cells; Insulinoma; Interleukin-1beta; Losartan; Mice; Mice, Inbred NOD; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pancreatic Neoplasms; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Pyridines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents

2007
PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
    Pharmacological research, 2007, Volume: 55, Issue:5

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Pioglitazone; PPAR gamma; Prediabetic State; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Rosiglitazone; Streptozocin; Thiazolidinediones; Vasoconstriction; Vasoconstrictor Agents

2007
Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
    Current eye research, 2007, Volume: 32, Issue:10

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Capillaries; Captopril; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Hyperglycemia; Leukostasis; Losartan; Male; Rats; Rats, Inbred Lew; Retina; Retinal Vessels; Vascular Cell Adhesion Molecule-1

2007
Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling.
    Canadian journal of physiology and pharmacology, 2008, Volume: 86, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Cells, Cultured; Glucose; Hyperglycemia; Insulin; Insulin Resistance; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction

2008
Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line.
    JOP : Journal of the pancreas, 2008, May-08, Volume: 9, Issue:3

    Topics: Angiotensin II; Animals; Cell Line; Dose-Response Relationship, Drug; Glucose; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Tissue Distribution

2008
Hyperglycemic action of angiotensin II in freely moving rats.
    Peptides, 1995, Volume: 16, Issue:3

    Topics: Analysis of Variance; Angiotensin II; Animals; Dose-Response Relationship, Drug; Hemorrhage; Hyperglycemia; Injections, Intravenous; Male; Movement; Rats; Rats, Wistar

1995
The cardiac renin-angiotensin system in STZ-induced diabetes.
    Diabetes, 1994, Volume: 43, Issue:10

    Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Gene Expression; Hyperglycemia; Imidazoles; Insulin; Kinetics; Losartan; Male; Myocardium; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Renin-Angiotensin System; RNA, Messenger; Tetrazoles

1994
Hyperglycemia alters cytoplasmic Ca2+ responses to capacitative Ca2+ influx in rat aortic smooth muscle cells.
    The American journal of physiology, 1995, Volume: 269, Issue:6 Pt 1

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Aorta; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Cells, Cultured; Cytoplasm; Hyperglycemia; Imidazoles; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Terpenes; Thapsigargin

1995
Effect of [1-Sar,8-Thr]-angiotensin II on the hyperglycemic response to hemorrhage in adrenodemedullated and guanethidine-treated rats.
    Regulatory peptides, 1995, Dec-07, Volume: 60, Issue:1

    Topics: Adrenal Medulla; Adrenergic Antagonists; Angiotensin II; Animals; Blood Glucose; Guanethidine; Hemorrhage; Hyperglycemia; Male; Rats; Rats, Wistar; Sympatholytics

1995
Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells.
    The American journal of physiology, 1997, Volume: 273, Issue:5

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Angiotensin II; Animals; Aorta; Arachidonate 12-Lipoxygenase; Cell Line, Transformed; Cells, Cultured; Endothelial Growth Factors; Gene Expression Regulation; Glucose; Humans; Hyperglycemia; Kinetics; Lymphokines; Muscle, Smooth, Vascular; RNA, Messenger; Swine; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1997
A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors.
    Medical hypotheses, 1998, Volume: 50, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Activation; Fish Oils; Heparitin Sulfate; Humans; Hyperglycemia; Kidney Glomerulus; Lipid Peroxidation; Models, Biological; Nitric Oxide; Protein Kinase C; Thromboxane A2; Transforming Growth Factor beta

1998
The reduction in alcohol intake in rats by isoproterenol is attenuated by indomethacin but not enalapril: relationship to blood glucose levels.
    Psychopharmacology, 1998, Volume: 138, Issue:2

    Topics: Adrenergic beta-Agonists; Alcohol Drinking; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Drinking; Enalapril; Ethanol; Hyperglycemia; Indomethacin; Isoproterenol; Male; Rats; Rats, Wistar

1998
The hyperglycemia induced by angiotensin II in rats is mediated by AT1 receptors.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1998, Volume: 31, Issue:10

    Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Antihypertensive Agents; Hyperglycemia; Losartan; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Vasoconstrictor Agents

1998
Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes.
    Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:7

    Topics: Angiotensin II; Animals; Aorta; Bradykinin; Cardiomegaly; Cattle; Coculture Techniques; Endothelium, Vascular; Glucose; Heart Ventricles; Hyperglycemia; Male; Myocardium; Phenylalanine; Rats; Rats, Sprague-Dawley

1999
Gluconeogenesis activation after intravenous angiotensin II in freely moving rats.
    Peptides, 1999, Volume: 20, Issue:7

    Topics: Angiotensin II; Animals; Blood Glucose; Carbon Radioisotopes; Gluconeogenesis; Hyperglycemia; Infusions, Intravenous; Kinetics; Liver; Rats

1999
Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells.
    The Journal of biological chemistry, 1999, Nov-05, Volume: 274, Issue:45

    Topics: Angiotensin II; Animals; Cell Division; Cells, Cultured; Glucose; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Tyrosine

1999
Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:1

    Topics: Acrylates; Adult; Angiotensin II; Diabetic Nephropathies; Glomerular Filtration Rate; Hemodynamics; Humans; Hyperglycemia; Imidazoles; Kidney; Male; Middle Aged; Renal Circulation; Renin; Renin-Angiotensin System; Thiophenes

2000
Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II, and nitric oxide inhibition.
    Transplantation, 2000, Jul-27, Volume: 70, Issue:2

    Topics: Adenosine; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Body Weight; Enzyme Inhibitors; Hematocrit; Hyperglycemia; Infusions, Intravenous; Injections; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Inbred WF; Regional Blood Flow

2000
Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.
    Circulation research, 2000, Oct-27, Volume: 87, Issue:9

    Topics: Alkyl and Aryl Transferases; Angiotensin II; Animals; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Genes, Reporter; Glycation End Products, Advanced; Hyperglycemia; Hyperinsulinism; Insulin; Luciferases; Muscle, Smooth, Vascular; NF-kappa B; Phosphorylation; Time Factors; Transcription, Genetic; Transfection

2000
Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death.
    Diabetes, 2001, Volume: 50, Issue:10

    Topics: Angiotensin II; Animals; Apoptosis; Cells, Cultured; DNA; Gene Expression Regulation; Glycosylation; Heart Ventricles; Hydrogen-Ion Concentration; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Losartan; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53

2001
Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors.
    Molecular and cellular endocrinology, 2002, Jun-28, Volume: 192, Issue:1-2

    Topics: Angiotensin II; Animals; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Division; Cells, Cultured; DNA; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Fetal Blood; Gene Expression Regulation; Glucose; Growth Substances; Hyperglycemia; Hyperplasia; Male; Muscle, Smooth, Vascular; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Rats; Rats, Sprague-Dawley; Transcription Factor RelA; Transcription Factors; Transcription, Genetic

2002
Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia.
    Diabetologia, 2002, Volume: 45, Issue:6

    Topics: Angiotensin II; Animals; Base Sequence; beta-Galactosidase; Binding Sites; Cell Line; Gene Expression Regulation; Genes, Reporter; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Recombinant Proteins; Swine; Transcription Factors; Transcriptional Activation; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.
    Diabetes, 1975, Volume: 24, Issue:2

    Topics: Adult; Aldosterone; Angiotensin II; Blood Glucose; Blood Volume; Diabetic Ketoacidosis; Female; Humans; Hyperaldosteronism; Hyperglycemia; Insulin; Ketosis; Male; Renin

1975
[Effect of increased plasma levels of glucose, adrenaline, and angiotensin upon glucose metabolism of totally ischemic and normally perfused rat brain].
    Acta biologica et medica Germanica, 1975, Volume: 34, Issue:11-12

    Topics: Angiotensin II; Animals; Blood Glucose; Brain; Epinephrine; Glucose; Hyperglycemia; Ischemia; Perfusion; Rats

1975
Mechanisms in rabbit aorta for hyperglycaemia-induced alterations in angiotensin II and norepinephrine effects.
    Diabetologia, 1992, Volume: 35, Issue:8

    Topics: Angiotensin II; Animals; Aorta; Glucose; Hyperglycemia; Inositol; Kinetics; Male; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Rabbits; Rubidium; Sodium-Potassium-Exchanging ATPase

1992
Morphology and functional responses of isolated zona glomerulosa cells of streptozotocin-induced diabetic rats.
    Experimental pathology, 1990, Volume: 39, Issue:2

    Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Corticosterone; Diabetes Mellitus, Experimental; Hyperglycemia; Male; Microscopy, Electron; Potassium; Rats; Rats, Inbred Strains; Streptozocin; Zona Glomerulosa

1990
Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems.
    Federation proceedings, 1985, Volume: 44, Issue:1 Pt 2

    Topics: Adrenal Medulla; Adrenocorticotropic Hormone; Angiotensin II; Animals; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Corticosterone; Corticotropin-Releasing Hormone; Dogs; Epinephrine; Heart Rate; Hyperglycemia; Norepinephrine; Rats; Sympathetic Nervous System

1985
Polyol pathway in aorta: regulation by hormones.
    Science (New York, N.Y.), 1969, Nov-21, Volume: 166, Issue:3908

    Topics: Alcohol Oxidoreductases; Angiotensin II; Animals; Aorta, Thoracic; Cyclic AMP; Epinephrine; Humans; Hyperglycemia; Isoproterenol; Norepinephrine; Ouabain; Rabbits; Sorbitol

1969
Studies on angiotensin-induced glycosuria.
    Mie medical journal, 1969, Volume: 19, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Glycosuria; Hyperglycemia; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Intravenous; Rabbits; Renin; Time Factors

1969
Effect of aldosterone on angiotensin-induced glycosuria.
    Mie medical journal, 1969, Volume: 19, Issue:1

    Topics: Aldosterone; Angiotensin II; Animals; Glycosuria; Hyperglycemia; Injections, Intravenous; Rabbits; Renin; Spironolactone; Time Factors; Urine

1969
Mechanism of angiotensin-induce glycosuria.
    Mie medical journal, 1969, Volume: 19, Issue:1

    Topics: Aldosterone; Angiotensin II; Animals; Blood Glucose; Epinephrine; Glycosuria; Hyperglycemia; Injections, Intravenous; Mouth; Rabbits; Spironolactone; Time Factors; Urine

1969